Provided by Tiger Trade Technology Pte. Ltd.

Day One Biopharmaceuticals Inc.

21.41
+0.01000.05%
Post-market: 21.420.0100+0.05%17:50 EDT
Volume:2.37M
Turnover:50.71M
Market Cap:2.21B
PE:-20.59
High:21.44
Open:21.43
Low:21.40
Close:21.40
52wk High:21.46
52wk Low:5.64
Shares:103.30M
Float Shares:78.77M
Volume Ratio:0.71
T/O Rate:3.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0400
EPS(LYR):-1.0400
ROE:-22.74%
ROA:-14.64%
PB:5.01
PE(LYR):-20.59

Loading ...

Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Major Issues Report

Form 8-K - Current report